Pulmovant
Developing inhaled therapies for patients with pulmonary diseases, starting with pulmonary hypertension associated
Highlights
- New on EvolcAdded 2026-11-14
About Pulmovant
Pulmovant develops therapies for pulmonary diseases. Its first investigational product is mosliciguat, an inhaled treatment in development for pulmonary hypertension associated with interstitial lung disease.
The company was founded in 2023 and is part of the Roivant family of companies. Its open roles cover clinical development, regulatory affairs, CMC, biostatistics and related functions.
Product: Mosliciguat, an investigational inhaled therapy for pulmonary hypertension associated with interstitial lung disease.
Jobs at Pulmovant
More biotech & pharma companies
Ratiotx
Develops targeted radiopharmaceuticals for treating cancer, from discovery through early clinical trialsNew on EvolcReCode Therapeutics
Develops mRNA and gene-correction medicines for people with genetically defined diseases, including cystic fibrosisNew on EvolcRecursion
AI-enabled drug discovery and development for pharmaceutical partners and patients with oncology and rare diseasesRemote-friendlySalary transparentRemix Therapeutics
Clinical-stage biotech developing small-molecule mRNA degraders for solid tumors and blood cancersNew on EvolcReplimune
Develops oncolytic immunotherapies for patients with cancer, including advanced melanomaResilience
Biologics and sterile drug product CDMO for biotech and pharma companies, from clinical batches to commercial supplyNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content delivery
- FastlyHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerx-served-by
- Response headerx-served-by
- Response headerx-served-by
Content management
- DrupalHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- Tailwind CSSMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
- Page markupsoftware structure signature
- Page markupsoftware structure signature
Hosting
- nginxHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Recruiting
- GreenhouseMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.